BioForce Nanosciences Holdings, Inc. Announces the Appointment of Michael Dunham to Its Board of Directors

Published: Oct 01, 2007

AMES, Iowa, Oct. 1, 2007 (PRIME NEWSWIRE) -- BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH), a company focused on the development and commercialization of nanotech tools and solutions for the life sciences, today announced the appointment of Michael Dunham to its Board of Directors. Mr. Dunham brings to BioForce his broad experience in high technology companies, which includes previously serving as a director for the nanotechnology company, Arryx Technology.

Back to news